Pepdexpepdex

How Is AHK-Cu Administered? Route & Timing

How is AHK-Cu administered?

This describes how AHK-Cu is typically administered in clinical and research references, not a self-administration guide. The usual route is Topical (most common) or sub-q, on a 1-2x daily topical schedule, generally over 8-12 weeks. Specific dosing is individual and beyond general information, and human evidence for AHK-Cu is limited.

Administration at a glance (reference data)

  • Route: Topical (most common) or sub-q
  • Schedule: 1-2x daily topical
  • Cycle length: 8-12 weeks
  • Half-life: ~2 hours topical

References

Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.

Last updated 2026-06-15.